Ma Amy W-S, Redka Dar'ya S, Pisterzi Luca F, Angers Stéphane, Wells James W
Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada M5S 3M2.
Biochemistry. 2007 Jul 3;46(26):7907-27. doi: 10.1021/bi6026105. Epub 2007 Jun 7.
FLAG- and HA-tagged M2 muscarinic receptors from coinfected Sf9 cells have been purified in digitonin-cholate and reconstituted into phospholipid vesicles. The purified receptor was predominantly monomeric: it showed no detectable coimmunoprecipitation; it migrated as a monomer during electrophoresis before or after cross-linking with bis(sulfosuccinimidyl)suberate; and it bound agonists and antagonists in a manner indicative of identical and mutually independent sites. Receptor cross-linked after reconstitution or after reconstitution and subsequent solubilization in digitonin-cholate migrated almost exclusively as a tetramer. The binding properties of the reconstituted receptor mimicked those reported previously for cardiac muscarinic receptors. The apparent capacity for N-[3H]methylscopolamine (NMS) was only 60% of that for [3H]quinuclidinylbenzilate (QNB), yet binding at saturating concentrations of [3H]QNB was inhibited fully and in a noncompetitive manner at comparatively low concentrations of unlabeled NMS. Reconstitution of the receptor with a saturating quantity of functional G proteins led to the appearance of three classes of sites for the agonist oxotremorine-M in assays with [3H]QNB; GMP-PNP caused an apparent interconversion from highest to lowest affinity and the concomitant emergence of a fourth class of intermediate affinity. All of the data can be described quantitatively in terms of cooperativity among four interacting sites, presumably within a tetramer; the effect of GMP-PNP can be accommodated as a shift in the distribution of tetramers between two states that differ in their cooperative properties. Monomers of the M2 receptor therefore can be assembled into tetramers with binding properties that closely resemble those of the muscarinic receptor in myocardial preparations.
从共感染的Sf9细胞中纯化得到的带有FLAG和HA标签的M2毒蕈碱受体,已在洋地黄皂苷 - 胆酸盐中进行了纯化,并重新组装到磷脂囊泡中。纯化后的受体主要为单体:未检测到共免疫沉淀;在与双(磺基琥珀酰亚胺基)辛二酸酯交联前后的电泳过程中,它均以单体形式迁移;并且它以一种表明存在相同且相互独立位点的方式结合激动剂和拮抗剂。在重新组装后或重新组装并随后在洋地黄皂苷 - 胆酸盐中溶解后交联的受体几乎完全以四聚体形式迁移。重新组装后的受体的结合特性与先前报道的心肌毒蕈碱受体的特性相似。N - [³H]甲基东莨菪碱(NMS)的表观容量仅为[³H]喹核醇基苯甲酸酯(QNB)的60%,然而在[³H]QNB饱和浓度下的结合,在相对低浓度的未标记NMS作用下被完全抑制且呈非竞争性。用饱和量的功能性G蛋白对受体进行重组,在使用[³H]QNB的测定中导致激动剂氧化震颤素 - M出现三类位点;鸟苷 - 5'-(β,γ - 亚氨基)三磷酸(GMP - PNP)导致从最高亲和力到最低亲和力的明显相互转化,并伴随出现第四类中等亲和力。所有数据都可以根据四个相互作用位点之间的协同作用进行定量描述,推测这些位点在一个四聚体内;GMP - PNP的作用可以解释为四聚体在两种具有不同协同特性的状态之间分布的转变。因此,M2受体的单体可以组装成四聚体,其结合特性与心肌制剂中的毒蕈碱受体非常相似。